SIP 1.55% $1.31 sigma pharmaceuticals limited

not a good look. No CEO. No CFO.There may be a good reason to...

  1. 76 Posts.
    not a good look. No CEO. No CFO.

    There may be a good reason to get rid of both of those people, however, I would think there would be limited reason of getting rid of both at the same time and with no replacement.

    I watch Orbis and Lazard with interest, but they don't get it right everytime. If they did, you would see returns from their funds smashing the daylights over the ASX benchmark.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.